Showing results (71-80 of 2,687) with videos related to
Sort By:
Pageof 269
Cancer Epidemiology|February 20, 2016
Human papillomavirus not detected in esophageal adenocarcinoma tumor specimensAnnika Antonsson, Lani Knight, David C Whiteman, et al.Cancer Epidemiology|February 22, 2016
Use of claims data to estimate annual cervical cancer screening percentages in Portland metropolitan area, OregonNasreen Abdullah, Robert S Laing, Susan Hariri, et al.Cancer Epidemiology|November 28, 2015
Perinatal and childhood factors and risk of breast cancer subtypes in adulthoodVirginia Lope, Esther García-Esquinas, Beatriz Pérez-Gómez, et al.Cancer Epidemiology|December 2, 2015
A multinational case-control study on childhood brain tumours, anthropogenic factors, birth characteristics and prenatal exposures: A validation of interview dataDanielle Vienneau, Denis Infanger, Maria Feychting, et al.Cancer Epidemiology|December 15, 2015
Adult narcoleptic patients have increased risk of cancer: A nationwide population-based studyChing-Min Tseng, Yung-Tai Chen, Chi-Wei Tao, et al.Cancer Epidemiology|December 15, 2015
Prostate cancer trends in Barbados: An analysis of the Barbados Urologic Diseases Survey databaseJustin B Emtage, Michael A Poch, Maisha T Hutton, et al.Cancer Epidemiology|December 15, 2015
Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based studyM Koëter, L N van Steenbergen, V E P P Lemmens, et al.Cancer Epidemiology|October 20, 2017
Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health InitiativeAshley S Felix, Amy Lehman, Randi E Foraker, et al.Cancer Epidemiology|July 23, 2022
Do prognoses of patients with second primary cancers differ from those of patients with no prior cancer? A population-based studyHaruka Kudo, Toshitaka Morishima, Makoto Fujii, et al.Cancer Epidemiology|June 25, 2018
The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trialsJoseph M Unger, William E Barlow, Catherine M Tangen, et al.Pageof 269